Maintenance therapy for acne vulgaris: Efficacy of a 12-month treatment with adapalene-benzoyl peroxide after oral isotretinoin and a review of the literature

Dermatology

Volumn 227, Issue 2, 2013, Pages 97-102

  Bettoli, Vincenzo ^a   Borghi, Alessandro ^a   Zauli, Stefania ^a   Toni, Giulia ^a   Ricci, Michela ^a   Giari, Silvia ^a   Virgili, Annarosa ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Acne, moderate to severe; Adapalene benzoyl peroxide fixed combination; Isotretinoin, oral; Maintenance therapy; Relapse

Indexed keywords

ADAPALENE PLUS BENZOYL PEROXIDE; CLINDAMYCIN; ISOTRETINOIN;

ACNE VULGARIS; ADOLESCENT; ANTIBIOTIC THERAPY; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GEL; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; TREATMENT DURATION;

ACNE VULGARIS; ADMINISTRATION, ORAL; BENZOYL PEROXIDE; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; ISOTRETINOIN; NAPHTHALENES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84888269738     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000350820     Document Type: Review

References (40)

1. Gollnick HP, Finlay AY, Shear N. Global Alliance to Improve Outcomes in Acne: Can we define acne as a chronic disease? If so, how and when? Am J Clin Dermatol 2008; 9: 279-284
2. Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, Shalita AR, Lozada VT, Berson D, Finlay A, Goh CL, Herane MI, Kaminsky A, Kubba R, Layton A, Miyachi Y, Perez M, Martin JP, Ramos-E-Silva M, See JA, Shear N, Wolf J Jr; Global Alliance to Improve Outcomes in Acne: New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 2009; 60 (5 suppl): S1-S50
3. Zane L. Acne maintenance therapy: expanding the role of topical retinoids? Arch Dermatol 2006; 142: 638-640
4. Thielitz A, Helmdach M, Röpke EM, Gollnick H. Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents. Br J Dermatol 2001; 145: 19-27
5. Piérard GE, Piérard-Franchimont C, Paquet P, Quatresooz P. Spotlight on adapalene. Expert Opin Drug Metab Toxicol 2009; 5: 1565-1575
6. Cunliffe WJ, Holland DB, Clark SM, Stables GI. Comedogenesis: some aetiological, clinical and therapeutic strategies. Dermatology 2003; 206: 11-16
7. Schmidt N, Gans EH. Tretinoin: a review of its anti-inflammatory properties in the treatment of acne. J Clin Aesthet Dermatol 2011; 4: 22-29
8. Shroot B, Michel S. Pharmacology and chemistry of adapalene. J Am Acad Dermatol 1997; 36: S96-S103
9. Tenaud I, Khammari A, Dreno B. In vitro modulation of TLR-2, CD 1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions. Exp Dermatol 2007; 16: 500-506
10. Kang S. The mechanism of action of topical retinoids. Cutis 2005; 75: 10-13
11. Gollnick H, Cunliffe WJ, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR, Thiboutot D; Global Alliance to Improve Outcomes in Acne: Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49(1 suppl): S1-S37
12. Borghi A, Mantovani L, Minghetti S, Giari S, Virgili A, Bettoli V. Low-cumulative dose isotretinoin treatment in mild-To-moderate acne: efficacy in achieving stable remission. J Eur Acad Dermatol Venereol 2011; 25: 1094-1098
13. Burke BM, Cunliffe WJ. The assessment of acne vulgaris-The Leeds technique. Br J Dermatol 1984; 111: 83-92
14. Cunliffe W, Gollnick H. Acne-Diagnosis and Management. London, Martin Dunitz, 2001
15. Borghi A, Mantovani L, Minghetti S, Virgili A, Bettoli V. Acute acne flare following isotretinoin administration: potential protective role of low starting dose. Dermatology 2009; 218: 178-180
16. Zouboulis CC. The truth behind this undeniable efficacy-recurrence rates and relapse risk factors of acne treatment with oral isotretinoin. Dermatology 2006; 212: 99-100
17. Harms M. Systemic isotretinoin (active ingredient of Roaccutane). Basel, Editions Roche, 1990
18. Chivot M, Midoun H. Isotretinoin and acne. A study of relapses. Dermatologica 1990; 180: 240-243
19. Layton AM, Knaggs H, Taylor J, Cunliffe WJ. Isotretinoin for acne vulgaris-10 years later: a safe and successful treatment. Br J Dermatol 1993; 129: 292-296
20. Stainforth JM, Layton AM, Taylor JP, Cunliffe WJ. Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course? Br J Dermatol 1993; 129: 297-301
21. Lehucher-Ceyrac D, Weber-Buisset MJ. Isotretinoin and acne in practice: a prospective analysis of 188 cases in 9 years. Dermatology 1993; 186: 123-128
22. Bettoli V, Lombardi AR, Pazzaglia M, Virgili A. Isotretinoina ed acne grave: esperienza personale in tema di recidive dopo un lungo periodo di follow-up. G Ital Dermatol Venereol 1998; 133: 333-336
23. Ng PPL, Goh CL. Treatment outcome of acne vulgaris with oral isotretinoin in 89 patients. Int J Dermatol 1999; 38: 213-216
24. Azoulay L, Oraichi D, Bérard A. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study. Br J Dermatol 2007; 157: 1240-1248
25. Liu A, Yang DJ, Gerhardstein PC, Hsu S. Relapse of acne following isotretinoin treatment: a retrospective study of 405 patients. J Drug Dermatol 2008; 7: 963-966
26. Quereux G, Volteau C, NGuyen JM, Dreno B. Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin. Dermatology 2006; 212: 168-176
27. White GM, Chen W, Yao J, Wolde-Tsadik G. Recurrence rates after the first course of isotretinoin. Arch Dermatol 1998; 134: 376-378
28. Haryati I, Jacinto SS. Profile of acne patients in the Philippines requiring a second course of oral isotretinoin. Int J Dermatol 2005; 44: 999-1001
29. Ghalamkarpour F, Nasiri S. Isotretinoin in treatment of acne: its efficacy, side effects, and recurrence rate of disease. Arch Iran Med 2006; 9: 228-230
30. Zhang JZ, Li LF, Tu YT, Zheng JJ. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat 2004; 15: 372-378
31. Thielitz A, Sidou F, Gollnick H. Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%. J Eur Acad Dermatol Venereol 2007; 21: 747-753
32. Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Kerrouche N, Arsonnaud S, Kang S. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 2006; 142: 597-602
33. Alirezai M, George SA, Coutts I, Roseeuw DI, Hachem JP, Kerrouche N, Sidou F, Soto P. Daily treatment with adapalene gel 0.1%maintains initial improvement of acne vulgaris previously treated with oral lymecycline. Eur J Dermatol 2007; 17: 45-51
34. Cassano N, Amoruso A, Alessandrini G, Biuso A, Carrieri G, Fai D, Gabellone M, Ligori P, Malvindi C, Mancino A. Treatment of inflammatory acne with a combination therapy with lymecycline and adapalene followed by maintenance treatment with adapalene. Eur J Inflamm 2004; 2: 45-52
35. Leyden J, Thiboutot DM, Shalita AR, Webster G, Washenik K, Strober BE, Shupack J. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallelgroup study. Arch Dermatol 2006; 142: 605-612
36. Vender R, Vender R. Double-blinded, vehicle-controlled proof of concept study to investigate the recurrence of inflammatory and noninflammatory acne lesions using tretinoin gel (microsphere) 0.04% in male patients after oral isotretinoin use. Dermatol Res Pract 2012; 2012: 736532
37. Gollnick HP, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol 2001; 11: 538-544
38. Poulin Y, Sanchez NP, Bucko A, Fowler J, Jarratt M, Kempers S, Kerrouche N, Dhuin JC, Kunynetz R. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial. Br J Dermatol 2011; 164: 1376-1382
39. Bettoli V, Mantovani L, Borghi A. Adapalene 0.1% cream after oral isotretinoin: evaluation of acne recurrence incidence. Rhodes: Medimond Monduzzi Editore International Proceedings, Division 15th Congress of the European Academy of Dermatology and Venereology, 2006
40. Miyachi Y, Hayashi N, Furukawa F, Akamatsu H, Matsunaga K, Watanabe S, Kawashima M. Acne management in Japan: study of patient adherence. Dermatology 2011; 223: 174-181